Please provide your email address to receive an email when new articles are posted on . The FDA has approved the expanded use area of Klisyri to up to 100 cm 2 on the face and scalp for the treatment ...

Sun Pharmaceutical Industries Limited (($IN:SUNPHARMA)) announced an update on their ongoing clinical study. Sun Pharmaceutical Industries Limited ...

Sun Pharmaceutical Industries Limited (($IN:SUNPHARMA)) announced an update on their ongoing clinical study. Sun Pharmaceutical Industries Limited ...

The approval was based on data from 2 multicenter, randomized, double-blind, phase 3 trials (ClinicalTrials.gov: NCT03285477 [N=351] and NCT03285490 [N=351]) that compared the efficacy and safety of ...

Actinic keratosis (AK) is a common precancerous lesion arising from cumulative ultraviolet exposure, often heralding the development of non-melanoma skin cancers such as basal cell carcinoma and ...

Dear Doctor K: I saw my doctor about a patch of rough, brown skin that I noticed on my upper arm. He said it is actinic keratosis and needs to be removed. Is it cancer? How will it be removed? Dear ...

Please provide your email address to receive an email when new articles are posted on . Patients and clinicians agreed overall skin appearance and texture were improved with tirbanibulin treatment.

Credit: Almirall. The expanded approval was based on data from a phase 3 safety study which evaluated tirbanibulin in more than 100 adult patients with actinic keratosis. Findings showed the safety ...

First-in-class microtubule inhibitor indicated for the topical treatment of actinic keratosis (AK) on the face or scalp with a 5-day application course Klisyri will be manufactured by Athenex Almirall ...

WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the ...

Background Actinic keratosis (AK) is a UV-induced, premalignant skin condition that is common in adults over 60 years of age with fair skin in Scotland. The most commonly prescribed first-line ...